Lukas Shumway
Stock Analyst at Barclays
(2.03)
# 3,283
Out of 4,988 analysts
16
Total ratings
64.3%
Success rate
1.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lukas Shumway
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLLS Cellectis | Downgraded: Sell | $9 → $1.3 | $3.25 | -60.00% | 3 | Sep 16, 2026 | |
| DRTS Alpha Tau Medical | Maintained: Buy | $17 → $30 | $14.33 | +109.35% | 6 | Sep 3, 2026 | |
| STRO Sutro Biopharma | Maintained: Buy | $56 | $20.47 | +173.57% | 3 | Aug 13, 2026 | |
| IMNM Immunome | Maintained: Buy | $36 | $27.33 | +31.72% | 4 | Aug 11, 2026 |
Cellectis
Sep 16, 2026
Downgraded: Sell
Price Target: $9 → $1.3
Current: $3.25
Upside: -60.00%
Alpha Tau Medical
Sep 3, 2026
Maintained: Buy
Price Target: $17 → $30
Current: $14.33
Upside: +109.35%
Sutro Biopharma
Aug 13, 2026
Maintained: Buy
Price Target: $56
Current: $20.47
Upside: +173.57%
Immunome
Aug 11, 2026
Maintained: Buy
Price Target: $36
Current: $27.33
Upside: +31.72%